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Abstract
The dermal compartment of skin is primarily composed of collagen-rich extracellular
matrix (ECM), which is produced by dermal fibroblasts. In Young skin, fibroblasts
attach to the ECM through integrins. During ageing, fragmentation of the dermal
ECM limits fibroblast attachment. This reduced attachment is associated with
decreased collagen production, a major cause of skin thinning and fragility, in the
elderly. Fibroblast attachment promotes assembly of the cellular actin cytoskeleton,
which generates mechanical forces needed for structural support. The mechanism(s)
linking reduced assembly of the actin cytoskeleton to decreased collagen production
remains unclear. Here, we report that disassembly of the actin cytoskeleton results
in impairment of TGF-b pathway, which controls collagen production, in dermal
fibroblasts. Cytoskeleton disassembly rapidly down-regulates TGF-b type II receptor
(TbRII) levels. This down-regulation leads to reduced activation of downstream
effectors Smad2/Smad3 and CCN2, resulting in decreased collagen production.
These responses are fully reversible; restoration of actin cytoskeleton assembly up-
regulates TbRII, Smad2/Smad3, CCN2 and collagen expression. Finally, actin
cytoskeleton-dependent reduction of TbRII is mediated by induction of microRNA
21, a potent inhibitor of TbRII protein expression. Our findings reveal a novel mech-
anism that links actin cytoskeleton assembly and collagen expression in dermal
fibroblasts. This mechanism likely contributes to loss of TbRII and collagen produc-
tion, which are observed in aged human skin.
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1 | INTRODUCTION
Loss of tissue mass and accumulation of tissue damage are common
features of ageing of many vital tissues.1,2 In human skin, these
age-associated features are readily observable as thinning and
fragility. The dermal extracellular matrix (ECM), which is composed
primarily of type I collagen fibrils, provides the majority of skin mass,
and is responsible for structural/mechanical support.3 Increased
fragmentation and reduced production of type I collagen fibrils are
prominent features of the skin dermis in aged individuals.4-9
Age-associated alterations of collagen fibrils also create a tissue
microenvironment that compromises skin health by impairing
vasculature function,2,10,11 delaying wound healing12-14 and promot-
ing skin cancer.15,16
In skin, fibroblasts are primarily responsible for synthesis of the
dermal ECM. In young healthy skin, dermal fibroblasts attach to
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intact, dense collagen fibrils, through integrin collagen receptors. This
attachment promotes assembly of the cellular actin cytoskeleton,
which generates mechanical forces that give rise to fibroblast mor-
phology.6,17-20 During ageing, collagen fibrils become fragmented,
less dense and disorganized.17 Fragmentation destroys attachment
sites, thereby diminishing the assembly of the actin cytoskeleton
within fibroblasts.
Assembly of the actin cytoskeleton, following integrin-dependent
attachment of fibroblasts to the dermal ECM, is a highly complex
process involving the co-ordinated assembly of a large number of
cytoskeletal proteins.21-25 Central to this process is the dynamic,
reversible polymerization of actin monomers to form microfilaments
that provide critical intracellular mechanical support.26-28
Production of ECM proteins by dermal fibroblasts is primarily regu-
lated by the TGF-b pathway. The actions of TGF-b are mediated by a
cell surface receptor complex, composed of type I and type II TGF-b
receptors, and downstream effector Smad proteins (Smad2, 3 and 4),
which are transcription factors. Smad proteins regulate many genes that
encode for components of the ECM, including collagens, laminins, fibro-
nectin and proteoglycans.5,9,29 In aged human skin, several components
of the TGF-b pathway are reduced.9,30 Impairment of the TGF-b path-
way like accounts, at least in part, for diminished ECM production that
is observed in aged skin. In this study, we used latrunculin A (Lat-A), a
potent inhibitor of actin,31,32 to investigate mechanisms that link assem-
bly of actin microfilaments to production of type I collagen, in human
skin fibroblasts. We find that interference with actin polymerization
impairs the TGF-b signalling pathway through specific down-regulation
of TGF-b type II receptor (TbRII). This down-regulation is mediated, in
part, by increased microRNA 21 (miR-21), which directly targets TbRII
synthesis. These data provide novel insights into mechanisms, by which
disassembly of the actin cytoskeleton may deleteriously alter fibroblast
function leading to age-associated skin atrophy.
2 | MATERIALS AND METHODS
2.1 | Materials
MEM a, GlutaMAXTM, Foetal Bovine Serum (FBS), 0.25% trypsin-
EDTA solution and Penicillin-Streptomycin were purchased from
GIBCO/Thermo Fisher (Wayne, MI, USA). Collagen I (rat tail) was
obtained from BD Biosciences (Palo Alto, CA, USA). TGF-b1 was
obtained from R&D Systems (Minneapolis, MN, USA). Latrunculin A
was obtained from Enzo Life Sciences (Farmingdale, NY, USA). TbRII
siRNA (AACGGTGCAGTCAAGTTTCCA) and miR-21 mimic (TAGCT-
TATCAGACTGATGTTGA) were purchased from Qiagen (Chatsworth,
CA, USA). miR-21 inhibitor (CAACATCAGTCTGATAAGCT) was pur-
chased from EXIQON (Woburn, MA, USA). All other reagents were
purchased from Sigma Chemical Company (St. Louis, MO, USA).
2.2 | Cell culture
Primary adult human dermal fibroblasts were prepared from full-
thickness punch biopsies (4 mm) obtained from sun-protected
buttock skin of healthy adult human volunteers (mean age
35  5 years). Dermal fibroblasts were isolated from skin biopsies
by digestion with bacterial collagenase (Worthington Biochemical
Corporation, Lakewood, NJ, USA). Early passage (less than 9
passages) dermal fibroblasts were cultured in MEM a, GlutaMAXTM
with 10% Foetal Bovine Serum (FBS) at incubator with 37°C, 5%
CO2. Three-dimensional (3D) collagen gels were made following a
previous publication with minor modification.17 Briefly, neutralized
rat tail type I collagen was mixed in cocktail (DMEM, NaHCO3
[44 mmol/L], L-glutamine [4 mmol/L], Folic Acid [9 mmol/L], and
neutralized with 1N NaOH to pH 7.2). Fibroblasts (0.5 x 106) were
suspended in 2 mL collagen and medium cocktail solution then pla-
ted in 35 mm bacterial culture dishes. After collagen polymerization,
collagen gels were incubated with 2 mL media (DMEM, 10% FBS) at
37°C, 5% CO2. For latrunculin A (Lat-A) experiment, cells were trea-
ted with Lat-A (30 nmol/L) for 24 hours.
2.3 | RNA isolation and quantitative real-time
RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen). cDNA
was prepared by reverse transcription of total RNA(100 ng) using a
TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster
City, CA, USA). Real-time PCR was performed on a 7300 real-time
PCR system (Applied Biosystems) using SYBR Green PCR Master
Mix (Applied Biosystems). Type I procollagen, CCN2 and TbRII pri-
mers were purchased from Applied Biosystems. Target gene mRNA
expression levels were normalized to the housekeeping gene 36B4
for quantification. miR-21 levels were determined by real-time PCR
using TaqMan MicroRNA Assays Kit (Life Technology, NY, USA)
following the manufacturer’s instructions.
2.4 | Western analysis
Western blots were performed as described previously.33 Briefly,
whole cell proteins were prepared using whole cell lysis buffer fol-
lowed by centrifugation. Equal amount of proteins (50 lg/lane) were
analysed for each sample by resolving on 10% SDS-PAGE. The SDS
gels were transferred to PVDF membrane; the membranes were
blocked with 5% milk-TBST for 1 hour at room temperature, fol-
lowed by incubation with primary antibodies for 1 hour at room
temperature. Primary antibodies: type I collagen (Southern Biotech,
Birmingham, AL, USA), CCN2 (SC-14939, L20, Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), TbRI (SC-398, V-22, Santa Cruz
Biotechnology), TbRII (SC-400, L-21, Santa Cruz Biotechnology), and
total and phospho-Smad3 (Cell Signalling Technology, Danvers, MA,
USA). The membranes were washed with TBST then incubated with
corresponding secondary antibodies for 1 hour at room temperature.
Followed by three times TBST washing, the blots were incubated in
ECF (Vistra ECF Western Blotting System, Amersham Pharmacia Bio-
tech, Piscataway, NJ, USA) following the manufacturer’s instructions.
The blots were scanned by STORM MolecularImager (Molecular
Dynamics, Sunnyvale, CA, USA). The intensities of each band were
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quantified using ImageQuant (GE HealthCare, Piscataway, NJ) and
normalized using b-actin as a marker for equal protein loading.
2.5 | ProteinSimple capillary electrophoresis
immunoassay
In some experiments, protein levels were determined by ProteinSimple
capillary electrophoresis immunoassay. ProteinSimple capillary elec-
trophoresis immunoassay overcomes many of the technical drawbacks
of Western analysis while providing much greater sensitivity, in the low
nanogram range. ProteinSimple capillary electrophoresis immunoassay
was performed according to the ProteinSimple manufacture’s user man-
ual. In brief, whole cell extract samples (800 ng/lane) were mixed with
kit provided master mix. The mixture was then heated at 95°C for
5 minutes. The samples including primary antibodies, blocking reagent,
HRP-conjugated secondary antibodies, chemiluminescent substrate and
separation and stacking matrices were also dispensed to designated
wells plate according to the ProteinSimple manufacture’s user manual.
The electrophoresis, blocking, washing and immunodetection steps
took place in the capillary system (ProteinSimple Wes, ProteinSimple,
Santa Clare, CA, USA) and were fully automated with instrument
default settings. Corresponding protein bands from digital images were
identified based on the molecular weight. The intensities of each pro-
tein were analysed by quantification with Compass software
(ProteinSimple) after normalization by and b-actin (loading control).
2.6 | Transient transfection, immunostaining, and
phalloidin staining
Primary adult human dermal fibroblasts were transiently transfected
with TbRII expression vector34 or siRNAs (TbRII siRNA, miR-21 mimic
and inhibitor) by electroporation using human dermal fibroblasts
nucleofector kit (Amaxa Biosystems, Gaithersburg, MD, USA).
Immunocytochemistry was performed as described previously.9
Briefly, cells were fixed in 4% PFA (paraformaldehyde) for 2 hours at
room temperature, followed by incubation with 0.5% Nonidet P-40,
blocking with 2% BSA (bovine serum albumin), washing with PBS five
times/the cells were then incubated with type I procollagen (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), CCN2 (SC-14939, L2,
Santa Cruz Biotechnology), Phospho Smad3 (ab52903, abcam, Cam-
bridge, MA,USA), TbRII (SC-400, L-21, Lot #: A1516, Santa Cruz
Biotechnology) primary antibodies for 1 hour at room temperature,
followed by incubation with Super Sensitive MultiLink (BioGenex, Fre-
mont CA, USA) for 10 minutes and streptavidin-conjugated AlexaFluor
594 or 488 (Invitrogen-Molecular Probes, San Diego, CA) for 10 min-
utes. Mounting medium with DAPI was added to stain cell nuclei. Cor-
responding IgG isotype (negative control) show no specific staining
(data not shown). Phalloidin was used to stain cells morphology.
2.7 | Statistical analysis
Comparisons between samples were performed with the paired t-
test (two groups) or the repeated measures of ANOVA (more than
two groups). Multiple pair-wise comparisons among samples were
made with the Tukey Studentized Range test. All P values are two-
tailed and considered significant when <.05.
3 | RESULTS
3.1 | Disassembly of actin cytoskeleton down-
regulates TGF-b type II receptor
To explore the connection between the actin cytoskeleton and dermal
fibroblast function, we disrupted the cytoskeleton with Lat-A, which
sequesters monomeric actin thereby causing rapid depolymerization
of actin microfibrils.35 As expected, Lat-A caused marked loss of actin
stress fibres (Figure 1A, left panel) and reduced the average surface
area of fibroblasts approximately 70% (Figure 1A, right panel).
We previously reported that the TGF-b pathway is regulated by
cell size and mechanical force regulate in dermal fibroblasts.36 When
fibroblasts contract and generate less mechanical force, TGF-b sig-
nalling is reduced.27 Therefore, we investigated whether disassembly
of the actin cytoskeleton, which reduces fibroblast size and mechani-
cal force, alters gene expression of TGF-b pathway components.
Cytoskeletal disassembly did not alter levels of TGF-b ligand TGF-
b2, TGF-b type I receptor (TbRI) or downstream effector Smads,
Smad2, Smad3, Smad4 or Smad7 (Figure 1B). In contrast, cytoskele-
tal disassembly increased gene expression of TGF-b ligands TGF-b1
and TGF-b3, and reduced expression of TGF-b type II receptor
(TbRII). This down-regulation of TbRII mRNA was accompanied by
significant reduction of TbRII protein (Figure 1C). TbRII protein was
significantly decreased by 78%.
3.2 | Actin cytoskeleton disassembly down-
regulates TGF-b/Smad signalling and TGF-b-regulated
type I procollagen and CCN2 expression
We next investigated the functional impact of actin cytoskeleton disas-
sembly on TGF-b signal transduction and target gene expression.
Indeed, we found that TGF-b-induced phosphorylation of the down-
stream effectors Smad2 and Smad3 was significantly inhibited by disas-
sembly of the actin cytoskeleton (Figure 2A). Phosphorylation of
Smad2/3 is necessary for TGF-b regulation of target genes. For exam-
ple, Smad3 activation is necessary for TGF-b induction of two genes
that are critical for ECM function, type I procollagen and CCN2 (connec-
tive tissue growth factor).9 Actin cytoskeleton disassembly significantly
reduced expression of both target genes. TGF-b induction of type I pro-
collagen mRNA (Figure 2B) and protein (Figure 2C) was reduced 58%
and 76%, respectively. TGF-b induction of CCN2 mRNA (Figure 2D)
and protein (Figure 2E) was reduced 72% and 80%, respectively.
Dermal fibroblasts reside within a three-dimensional (3D) colla-
gen fibril-rich ECM microenvironment in human skin. Accordingly,
we investigated the impact of actin cytoskeleton disassembly on
type I procollagen and CCN2 expression in fibroblasts cultured
within 3D collagen lattices. In 3D collagen cultures, consistent with
monolayer culture (Figure 1A), depolymerization of the actin
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cytoskeleton resulted in decreased fibroblast surface area (Figure 2F,
right panel), and reduced expression of type I procollagen and CCN2
mRNA (Figure 2G) and protein (Figure 2H).
3.3 | Actin cytoskeleton assembly stimulates TGF-b
signalling and type I procollagen expression
Inhibition of actin microfibril formation by Lat-A has been shown to be
rapidly reversible.37-38 This reversibility provides a unique opportunity
to control cytoskeletal assembly and determine its role in fibroblast
functions. Therefore, we next assessed the impact of actin cytoskele-
ton assembly on TGF-b signalling and gene regulation. For these stud-
ies, fibroblasts were first treated with Lat-A or vehicle for 24 hours,
and then Lat-A-containing media were replaced with normal media.
Within 24 hours after removal of Lat-A, distinct actin microfibrils were
observed (Figure 3A). Importantly, TbRII protein levels were also
restored to pre-Lat-A treatment levels (Figure 3B). This restoration of
TbRII was associated with enhanced signal transduction, as demon-
strated by increased TGF-b-induced Smad2/Smad3 phosphorylation
(Figure 3C). In addition, consistent with up-regulation of TGF-b
signalling, TGF-b induction of both type I procollagen and CCN2 pro-
tein levels was significantly elevated (Figure 3D).
3.4 | TbRII down-regulation mediates impaired
TGF-b signalling and type I procollagen production by
actin cytoskeleton disassembly
The above data indicate that the TGF-b pathway is regulated by the
state of actin cytoskeleton assembly and suggest that TbRII is a criti-
cal mediator of this regulation. To investigate this possibility, we
determined the impact of loss or gain of TbRII. We confirmed that
TbRII siRNA efficiently reduced the expression of TbRII and TGF-b1
induced Smad3 phosphorylation (Figure 4A). As expected, removal
of Lat-A restored TGF-b signalling (Figure 4, fourth panel from the
left). In contrast, siRNA-mediated knockdown of TbRII blocked
restoration of TGF-b signalling following removal Lat-A (Figure 4B,
last panel). We also found that prevention of TbRII down-regulation,
by transfection of TbRII expression vector, blocked down-regulation
of type I procollagen (Figure 4C, upper row) and CCN2 (Figure 4C,
F IGURE 1 Actin cytoskeleton disassembly down-regulates TGF-b type II receptor. Dermal fibroblasts were treated with Lat-A (30 nmol/L)
or DMSO (CTRL) for 24 h. A, Dermal fibroblasts were stained with phalloidin and imaged by fluorescence microscopy. Red fluorescence
delineates cell cytoplasm; blue fluorescence delineates nuclei. The relative cell surface areas were quantified by ImageJ software. Arrow heads
indicate stretched actin fibres. Mean  SEM, N = 6, *P < .05 vs CTRL. Scale bars = 100 lm. B, mRNA levels of TGF-b pathway components
were quantified by real-time RT-PCR and normalized to the housekeeping gene 36B4. Mean  SEM, N = 3, *P < .05 vs CTRL. C, TbRI and
TbRII protein levels were determined by Western blot and normalized to b-actin (loading control). Band intensities were quantified by
MolecularImager. Inset shows representative Western blot. Mean  SEM, N = 3, *P < .05 vs CTRL
F IGURE 2 Actin cytoskeleton disassembly down-regulates TGF-b/Smad signalling and TGF-b regulated type I procollagen and CCN2
expression. Dermal fibroblasts were treated with Lat-A (30 nmol/L) or DMSO (control) for 24 h. A, Smad2/Smad3 phosphorylation. Cells were
treated with TGF-b1 (5 ng/mL) for 1 h. N = 3, *P < .05 vs CTRL with TGF-b1. B, Type I procollagen mRNA levels. Mean  SEM. N = 3,
*P < .05. C, Type I procollagen protein levels. Mean  SEM, N = 3, *P < .05. D, CCN2 mRNA levels. Mean  SEM. N = 3, *P < .05. E, CCN2
protein levels. Mean  SEM, N = 3, *P < .05. F, Cells were cultured in type I collagen lattices, stained with phalloidin and imaged by
fluorescence microscopy. Red fluorescence delineates cell cytoplasm; blue fluorescence delineates nuclei. Arrow heads indicate stretched actin
fibres. Representative image of three independent experiments. Scale bar = 100 lm. G, Type I procollagen and CCN2 mRNA levels.
Mean  SEM. N = 3, *P < .05 vs CTRL. H, Type I procollagen and CCN2 protein levels. Mean  SEM. N = 3, *P < .05 vs CTRL. mRNA levels
were quantified by real-time RT-PCR and normalized to the housekeeping gene 36B4. Protein levels were determined by Western blot analysis
and normalized by b-actin (loading control). Band intensities were quantified by MolecularImager. Inset shows representative Western blot
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lower row) protein expression, following Lat-A-mediated actin
cytoskeleton disassembly. In contrast, expression of TbRII did not
prevent Lat-A-mediated actin cytoskeleton disassembly (Figure 4D).
These data demonstrate that modulation of TbRII expression in
response to the state of actin cytoskeleton assembly plays a key role
in regulation of TGF-b signalling and production of type I collagen
and CCN2.
3.5 | Reduction of fibroblast size per se does not
down-regulate TGF-b signalling or TbRII
Integrins are cell surface receptors that bind to the ECM and link
the ECM to the intracellular actin cytoskeleton. Integrins thereby
play a critical role in normal cell attachment and spreading.39,40
Disassembly of the actin cytoskeleton reduces cell spreading. We
F IGURE 3 Actin cytoskeleton assembly stimulates TGF-b signalling and type I procollagen expression. Dermal fibroblasts were treated with
Lat-A (30 nmol/L) or DMSO (control) for 24 h. Lat-A-containing media was withdrawn 24 h after its addition, followed by extensive washing
with PBS and addition of fresh culture media. The cells were incubated for another 24 h after removal of Lat-A. A, Cells were stained with
phalloidin (red) to image the actin cytoskeleton and DAPI (blue) to image nuclei. The relative cell surface areas were quantified by ImageJ
software. Arrow heads indicate stretched actin fibres. Mean  SEM, N = 6, *P < .05. Scale bar = 100 lm. B, TbRII protein levels.
Mean  SEM, N = 4, *P < .05. C, Smad2/Smad3 phosphorylation. Cells were treated with TGF-b1 (5 ng/mL) for 1 h. D, Type I procollagen
(Col-1) and CCN2 protein levels. Mean  SEM, N = 3, *P < .05 vs CTRL. Protein levels were determined by Western blot analysis and
normalized to b-actin (loading control). Band intensities were quantified by MolecularImager. Inset shows representative Western blot
F IGURE 4 Down-regulation of TbRII mediates impaired TGF-b signalling and type I procollagen production by actin cytoskeleton disassembly.
A, Knockdown of TbRII expression by TbRII siRNA. Cells were transfected with control siRNA or TbRII siRNA. Two days, cells were treated with
vehicle or TGF-b1 (5 ng/mL) for 1 h. TbRII and Smad3 phosphorylation (p-Smad3) was determined by Western blot. Protein levels were
normalized to b-actin (loading control). Band intensities were quantified by MolecularImager. Inset shows representative Western blot.
Mean  SEM, N = 3, *P < .05 vs CTRL. B, Dermal fibroblasts were treated with Lat-A (30 nmol/L) or DMSO (control, CTRL) for 24 h. Culture
media were removed 24 h later, followed by extensive washing with PBS and replacement with fresh media alone (Lat-A withdrawal) or containing
Lat-A. Cells were transfected with control siRNA or TbRII siRNA, as indicated. Twenty-four hours later, cells were treated with vehicle or TGF-b1
(5 ng/mL) for 1 h. Smad3 phosphorylation (p-Smad3) was determined by immunostaining (red). Nuclei were stained with DAPI (blue). Scale
bars = 100 lm. C, Fibroblasts were transfected with TbRII expression vector, and 48 h later treated with Lat-A (30 nmol/L) for 24 h. Cells were
stained for TbRII (green) and type I procollagen (Col-1, red, top row), or CCN2 (red, lower row) by immunofluorescence. Nuclei were stained with
DAPI (blue). Arrow heads indicate cells with reduced TbRII. Of note, these cells also displayed reduced expression of Col-1 and CCN2. Scale
bars = 100 lm. D, Cells were transfected with control vector or TbRII expression vector for 48 h, then treated with vehicle or Lat-A (30 nmol/L)
for 24 h. The actin cytoskeleton was stained with phalloidin (red) and imaged by fluorescence microscopy. Nuclei were stained with DAPI. Arrow
heads indicate stretched actin fibres. All images are representative of three independent experiments. Scale bars = 100 lm
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investigated whether reduced fibroblast spreading, under conditions
of integrin-independent cell attachment, exerts similar effects on
TGF-b signalling as reduced cell spreading due to cytoskeleton disas-
sembly by Lat-A treatment. For these studies, dermal fibroblasts
were cultured on poly-L-lysine coated surfaces, which allow integrin-
independent attachment and spreading.41 Under these conditions,
fibroblasts displayed limited spreading and reduced cell surface area
(Figure S1A left panel), compared to cultures on uncoated, standard
tissue culture plates (Figure S1B left panel). Interestingly, this
reduced spreading did not alter TGF-b-induced Smad3 phosphoryla-
tion (Figures S1A,B) or TbRII expression (Figure S1C), compared to
fully spread fibroblasts.
To further explore the relationship between reduced fibroblast
spreading and TGF-b signalling, we examined cells at early times after
attachment to standard tissue culture plates, prior to full spreading.
Although fibroblasts displayed limited spreading at 30 and 60 minutes
after attachment, compared to 24 hours after attachment, TGF-b-
induced Smad3 phosphorylation was similar at all time-points.
3.6 | Actin cytoskeleton disassembly induces
miR-21, which reduces TbRII expression
Finally, we explored the potential mechanism by which actin
cytoskeleton disassembly reduces TbRII expression. Several recent
reports indicate that TbRII expression is largely regulated by micro-
RNA 21 (miR-21) in both stromal (adipose tissue-derived mesenchy-
mal stem cells) and epithelial cells (colon cancer cell lines, HCT-116
and HT-29).42,43 miR-21 regulates TbRII expression through direct
interaction with the 30 non-translated region in the TbRII transcript.
Interestingly, we observed that actin cytoskeleton disassembly leads
to significant induction of miR-21 levels (Figure 5A). Furthermore,
we found that miR-21 mimic significantly down-regulated TbRII pro-
tein level, whereas miR-21 inhibitor significantly increased TbRII pro-
tein level in human dermal fibroblasts (Figure 5B). Importantly,
blocking miR-21 induction by miR-21 inhibitor prevented suppres-
sion of TbRII by actin cytoskeleton disassembly (Figure 5C). We also
confirmed that miR-21 mimic inhibited Smad3 phosphorylation (Fig-
ure 5D,E) and reduced the expression of TbRII, and TGF-b target
genes, type I collagen and CCN2 (Figure 5F).
4 | DISCUSSION
Fibroblasts in young skin attach to dense, intact collagen fibrils,
which compose the bulk of skin dermal ECM connective tissue. This
attachment promotes assembly of the actin cytoskeleton and gener-
ation of mechanical force. During ageing, dermal collagen fibrils
become fragmented and disorganized.17,18,20 This degeneration of
the dermal ECM impairs fibroblast attachment and consequent
assembly of the intracellular actin cytoskeleton. Decline of collagen
production by fibroblasts is a prominent feature of skin ageing.5,6,9,44
Emerging evidence indicates that cell-substrate attachment and
assembly of the actin cytoskeleton, play critical roles in diverse cellu-
lar biological processes, such as proliferation, differentiation, signal
transduction and gene expression.22,23 Here, we explored the impact
of disassembly of the actin cytoskeleton on the regulation of colla-
gen production by dermal fibroblasts. Our results indicate that disas-
sembly of actin cytoskeleton leads to down-regulation of collagen
production via impairment of TGF-b/Smad signalling. These data
suggest that reduced assembly of the actin cytoskeleton in aged
skin, due to fragmentation of collagen fibrils in the dermal ECM, may
contribute to age-related collagen loss, in human skin.
The TGF-b/Smad signalling pathway is a major regulator of ECM
production.9,31,45,46 TGF-b initiates its biological actions through
interactions with the TGF-b receptor complex.47 TGF-b binding to
TbRII is required to initiate the TGF-b signalling pathway. Binding of
TGF-b to TbRII triggers its association with TbRI, which phosphory-
lates and activates downstream Smad effectors. We found that actin
F IGURE 5 Actin cytoskeleton disassembly induces miR-21, which reduces TbRII expression. A, miR-21 expression levels. Dermal fibroblasts
were treated with Lat-A (30 nmol/L) or DMSO (CTRL) for 24 h. miR-21 levels were determined by real-time PCR and normalized to RNU6B,
endogenous reference siRNA. Mean  SEM, N = 3, *P < .05 vs CTRL. B, TbRII protein levels. Cells were transfected with control siRNA, miR-
21 mimic or miR-21 inhibitor for 48 h. Protein levels were determined by capillary electrophoresis immunoassay. Mean  SEM, N = 3,
*P < .05 vs CTRL siRNA. C, TbRII protein levels. Cells were transfected with control siRNA or miR-21 inhibitor for 48 h, then treated with Lat-
A (30 nmol/L) or DMSO (control) for 24 h. Protein levels were determined by capillary electrophoresis immunoassay. Mean  SEM, N = 3,
*P < .05. D, miR-21 mimic inhibits Smad3 phosphorylation. Cells were transfected with control siRNA or miR-21 mimic for 2 d. Cells were
treated with vehicle or TGF-b1 (5 ng/mL) for 1 h. Smad3 phosphorylation was determined by capillary electrophoresis immunoassay. E, miR-21
mimic inhibits Smad3 phosphorylation. Cells were transfected with control siRNA or miR-21 mimic for 2 d. Cells were treated with vehicle or
TGF-b1 (5 ng/mL) for 1 h. Smad3 phosphorylation (p-Smad3) was determined by immunostaining (red). Nuclei were stained with DAPI (blue).
Images are representative of three independent experiments. Scale bars = 50 lm. F, miR-21 mimic inhibits type I collagen and CCN2
expression. Cells were transfected with control siRNA or miR-21 mimic for 2 d. Type I procollagen and CCN2 protein levels were determined
by Western blot and normalized to b-actin (loading control). Band intensities were quantified by MolecularImager. Inset shows representative
Western blot. Mean  SEM, N = 3, *P < .05 vs CTRL siRNA. Protein levels (B-D) were determined by capillary electrophoresis immunoassay
and normalized to b-actin (loading control). Band intensities were quantified by Compass software. Inset shows representative digital images.
G, Diagram illustrating proposed mechanism of age-related skin thinning and fragility. Collagen fibril fragmentation reduced fibroblast
attachment, and actin cytoskeleton disassembly act in concert to up-regulate miR-21, which in turn impairs TGF-b signalling via specific down-
regulation of TbRII. Impaired TGF-b signalling reduces production of collagen and other ECM proteins, which eventuates in loss of dermal
mass, giving rise to thin, fragile skin, a prominent feature of aged human skin
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cytoskeleton disassembly down-regulated TbRII, without affecting
TbRI expression. Three distinct isoforms of TGF-b (b1, b2 and b3)
have been identified in mammalian cells.48 Although they are struc-
turally homologous, TGF-b1 and TGF-b3 bind to TbRII with higher
affinity than TGF-b2 in most cells.49,50 Cytoskeleton disassembly
modestly induced TGF-b1 and TGF-b3. This induction may reflect a
compensatory response to down-regulation of TbRII. In skin fibrob-
lasts, reduction of TbRII, without reduction of TbRI, results in loss of
cellular binding of TGF-b and impairment of downstream Smad sig-
nalling.51 Thus, cytoskeleton disassembly impairs the first step of
TGF-b signalling by substantially reducing TbRII expression.
The actin cytoskeleton plays a critical role in the maintenance of
the structural integrity of the cell and diverse dynamic cellular func-
tions. As such, disassembly of actin filaments affects many cellular
processes. Our data identify TbRII expression as the major mecha-
nism, by which actin cytoskeleton assembly regulates collagen pro-
duction. Actin cytoskeleton assembly is known to regulate other
pathways, including Hippo signalling52 and MRT/SRF dependent
gene expression.26
Integrins function as primary cell surface receptors for attach-
ment of cells to the ECM. As such, integrins serve as physical links
between the ECM and the intracellular actin cytoskeleton. Together,
the actin cytoskeleton and integrins generate mechanical force.
We found that limited fibroblast spreading, due to either integrin-
independent cell attachment, or at early times after integrin-
mediated attachment, does not reduce TbRII or impair TGF-b
signalling (Figures S1 and S2). These data support the conclusion
that actin cytoskeletal disassembly, rather than reduced fibroblast
spreading per se, down-regulates TbRII, leading to reduced collagen
production.
Interestingly, miR-21, a potent inhibitor of TbRII expression,42,43
is induced by actin cytoskeleton disassembly and mediates TbRII
down-regulation. These data suggest that expression of miR-21 may
be regulated, in part, by cellular mechanical sensing mechanisms. The
transcription factor activator protein 1 (AP-1) has been reported to
directly regulate expression of miR-21 through several response ele-
ments in the miR-21 promoter.53 We have previously reported that
reduced mechanical force elevates AP-1 activity in human dermal
fibroblasts,17 suggesting that miR-21 elevation in response to actin
cytoskeleton disassembly may result from activation of AP-1. Addi-
tionally, we reported that reduced mechanical force increases reac-
tive oxygen species (ROS), which induce AP-1,54 in human dermal
fibroblasts.17,56 Interestingly, elevated ROS specifically down-regu-
lates TbRII, without affecting TbRI.34 These data support the possi-
bility that actin cytoskeleton disassembly may up-regulate miR-21
through ROS-mediated AP-1 activation, leading to down-regulation
of TbRII. Obviously, additional studies are needed to address the
detailed molecular mechanism(s) of actin cytoskeleton-specific down-
regulation of TbRII expression.
We and others have previously shown that many TGF-b/
Smad-regulated ECM proteins are down-regulated in aged human
skin.9,44 Importantly, we observed down-regulation TbRII in natu-
rally aged,30 photoaged,30 and acute ultraviolet-irradiated human
skin in vivo,51 with no change of TbRI expression. These data
indicate that TbRII and TbRI are differentially regulated and that
TbRII specific down-regulation may play a key role in impaired
TGF-b/Smad signalling and reduced ECM synthesis that are
observed in aged human skin.
Recently, we reported that enhancing mechanical support within
the dermis by direct injection of dermal filler (cross-linked hyaluronic
acid) into aged human skin in vivo increases TbRII levels, and stimu-
lates collagen and CCN2 expression.56,57 These data indicate that
dermal fibroblasts in aged human skin retain their capacity to up-reg-
ulate the TGF-b pathway and produce collagen. Thus, loss of struc-
tural integrity of the dermal ECM, with concomitant reduced
attachment and actin cytoskeleton disassembly, may be drive the
decline of collagen production by fibroblasts in aged human skin.
In summary, we report that disassembly of actin cytoskeleton
leads to down-regulation of type I collagen via impairment of
TGF-b/Smad signalling. Actin cytoskeleton disassembly up-regulates
miR-21, which in turn impairs TGF-b signalling via specific down-reg-
ulation of TbRII. These findings provide mechanistic insight regarding
reduced expression of TbRII and type I collagen, which are observed
in aged human skin (Figure 5G).
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